News & Comment

Filter By:

Year
  • In our first monthly round up of the year we explore the big stories from 2020, including key biopharma deals, FDA approvals and IPOs, as well as the extraordinary impact of COVID-19 on science throughout an unusual 12 months.

    • Raveena Bhambra
    News Feature